Riess H - Search Results

1

Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions.

Riess H, Prandoni P, Harder S, Kreher S, Bauersachs R. Riess H, et al. Crit Rev Oncol Hematol. 2018 Dec;132:169-179. doi: 10.1016/j.critrevonc.2018.09.015. Epub 2018 Sep 29. Crit Rev Oncol Hematol. 2018. PMID: 30447923 Review.

2

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Riess H, Ay C, Bauersachs R, Becattini C, Beyer-Westendorf J, Cajfinger F, Chau I, Cohen AT, Khorana AA, Maraveyas A, Renni M, Young AM. Riess H, et al. Oncologist. 2018 Jul;23(7):822-839. doi: 10.1634/theoncologist.2017-0473. Epub 2018 Apr 12. Oncologist. 2018. PMID: 29650686 Free PMC article. Review.

3

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism.

Beyer-Westendorf J, Klamroth R, Kreher S, Langer F, Matzdorff A, Riess H. Beyer-Westendorf J, et al. Among authors: riess h. Dtsch Arztebl Int. 2019 Jan 18;116(3):31-38. doi: 10.3238/arztebl.2019.0031. Dtsch Arztebl Int. 2019. PMID: 30832760 Free PMC article.

4

Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management.

Riess H, Verhamme P, Weitz JI, Young A, Bauersachs R, Beyer-Westendorf J, Crowther M, Maraveyas A. Riess H, et al. Crit Rev Oncol Hematol. 2021 Jan;157:103125. doi: 10.1016/j.critrevonc.2020.103125. Epub 2020 Oct 20. Crit Rev Oncol Hematol. 2021. PMID: 33254037 Review.

5

[Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].

Kreher S, Riess H. Kreher S, et al. Among authors: riess h. Internist (Berl). 2014 Apr;55(4):448-54. doi: 10.1007/s00108-014-3476-z. Internist (Berl). 2014. PMID: 24599489 German.

6

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.).

Kreher S, Ochsenreither S, Trappe RU, Pabinger I, Bergmann F, Petrides PE, Koschmieder S, Matzdorff A, Tiede A, Griesshammer M, Riess H; Haemostasis Working Party of the German Society of Hematology and Oncology; Austrian Society of Hematology and Oncology; Society of Thrombosis and Haemostasis Research. Kreher S, et al. Among authors: riess h. Ann Hematol. 2014 Dec;93(12):1953-63. doi: 10.1007/s00277-014-2224-8. Epub 2014 Oct 14. Ann Hematol. 2014. PMID: 25307456

7

[CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].

Riess H, Sinn M, Kreher S; für den Arbeitskreis Hämostaseologie der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO). Riess H, et al. Dtsch Med Wochenschr. 2015 Jun;140 Suppl 1:S22-3. doi: 10.1055/s-0041-101770. Epub 2015 Jun 11. Dtsch Med Wochenschr. 2015. PMID: 26069043 Clinical Trial. German. No abstract available.

8

CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Melzer N, Bramlage P, Riess H. Bauersachs R, et al. Among authors: riess h. Thromb Haemost. 2011 Jun;105(6):981-8. doi: 10.1160/TH10-09-0614. Epub 2011 Apr 20. Thromb Haemost. 2011. PMID: 21505722 Clinical Trial.

9

Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).

Appelmann I, Kreher S, Parmentier S, Wolf HH, Bisping G, Kirschner M, Bergmann F, Schilling K, Brümmendorf TH, Petrides PE, Tiede A, Matzdorff A, Griesshammer M, Riess H, Koschmieder S. Appelmann I, et al. Among authors: riess h. Ann Hematol. 2016 Apr;95(5):707-18. doi: 10.1007/s00277-016-2621-2. Epub 2016 Feb 26. Ann Hematol. 2016. PMID: 26916570 Review.

10

[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].

Schellong SM, Riess H, Spannagl M, Omran H, Schwarzbach M, Langer F, Gogarten W, Bramlage P, Bauersachs RM. Schellong SM, et al. Among authors: riess h. Internist (Berl). 2018 Jul;59(7):744-752. doi: 10.1007/s00108-018-0447-9. Internist (Berl). 2018. PMID: 29946874 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page